Biomind Labs Inc. BMNDF
Set alert
0.25 USD 0.00 0.00%
At close · Oct 30
0.2502 Day range 0.2502
0.011 52-week range 0.80
- YTD
- +119.47%
- 1 year
- +1,483.54%
- Open
- 0.2502
- Prev close
- 0.2502
- Mkt cap
- 19.41M
- Vol
- 1.00K
- Avg vol
- 1.05K
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.2502
- High
- 0.2502
2Y chart
Signals (36)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| RSI: Overbought | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| RSI: Oversold | Jul 1, 2026 | 4 months ago |
| MACD: Sell Signal | May 13, 2026 | 5 months ago |
| RSI: Overbought | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 21, 2026 | 6 months ago |
| RSI: Overbought | Apr 21, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| SMA: Bearish | Mar 17, 2026 | 7 months ago |
| RSI: Oversold | Mar 17, 2026 | 7 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Dec 19, 2025 | 10 months ago |
| MACD: Buy Signal | Aug 26, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| RSI: Oversold | Jun 16, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 13, 2025 | 1 year ago |
| RSI: Overbought | Jan 13, 2025 | 1 year ago |
News
- Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
- Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
- Biomind Labs Announces CAD $2.52 Million Private Placement Financing
- Biomind Labs Accelerates FDA Pathway for 5-MEO-DMT Candidate BMND08 with Proprietary Nano-Formulation as Patent Observations Are Successfully Withstood
- Biomind Labs Announces Revocation of Cease Trade Order
- Biomind Labs Announces Filing of Continuous Disclosure Documents and Appointment of Scott Ackerman to the Board
- Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
- Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways
- Biomind Labs Announces Unprecedented Positive Results of Phase 2 Clinical Trial of BMND08 for Depression & Anxiety in Alzheimer's Disease
- Biomind Labs Provides Corporate Update
Your note
Sign in to keep a note on BMNDF — it syncs with the Stock Master app.